HealthFirst Mail-In Monitoring System (HF Acquisition) – Envelope Printing Error (2024)
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Biological, Bio52 HealthFirst Mail In Monitoring System, 52 Tests, Item: 1003600. Biological, Bio12 HealthFirst Mail In Monitoring System, 12 Tests, Item: 1003580
Brand
HF Acquisition Co LLC
Lot Codes / Batch Numbers
Not specified in FDA notice. Check official source for details.
Products Sold
Item/UDI-DI/Lot(Expiration): 1003600/10850065007820/ 2301060(11/30/2024) 2302261(11/30/2024) 2307261(12/31/2024 2312260(1/31/2025) 2313062(1/31/2025) 2331880(6/30/2025) 2401664(8/31/2025) 2414060(2/28/2026) 2414862(3/31/2026) 2414870(3/31/2026) 2416470(3/31/2026) 2416481(4/30/2026) 2416482(4/30/2026) 1003580/10850065007813/2421181(5/31/2026)
HF Acquisition Co LLC is recalling Biological, Bio52 HealthFirst Mail In Monitoring System, 52 Tests, Item: 1003600. Biological, Bio12 due to Spore test strip monitoring system, designed for routine monitoring of sterilization processes, may have a printing error on the return envelope that . Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Spore test strip monitoring system, designed for routine monitoring of sterilization processes, may have a printing error on the return envelope that may cause spore test results to be reported to the incorrect customer's account.
Recommended Action
Per FDA guidance
On 12/11/2024, correction notices were mailed to customers asking them to do the following: 1. Check the box number on your Biological Weekly Monitoring kit for the affected lot numbers. The box number is located under the bar code on the outside of the box (see image below). 3. Check the serial number on all test strip return envelopes located in the box. This number is the last set of digits in the alphanumeric string located to the left of the bar code on the envelope. 4. Verify that the box number matches the last three digits of the serial number on the return envelope. 5. If the numbers do not match, you are hereby instructed to isolate your inventory of the above-listed lot numbers and dispose of it in regular trash. Firm will work with you on replacement product. 6. Ensure this letter is promptly brought to the attention of those responsible for managing the medical device inventory. Distribute this notification to all device users within your facility and network to ensure they are informed of this field correction letter. Please share this notification with any organizations that have received the potentially affected devices. 7. Complete and return the response form via email to quality@healthfirst.com Should you have any questions about this urgent field correction, please contact Customer Service at 855-476-1342 or email us at customerservice@healthfirst.com.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
AL, AK, AZ, AR, CA, CO, CT, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV, WI, WY, DC
Page updated: Jan 10, 2026